Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debebe Theodros

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Research|May 25, 2019
Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic ProgressionRobert M Hughes, Brian W Simons, Hamda Khan, et al.
Journal for Immunotherapy of Cancer|May 19, 2016
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial gliomaMira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Oncoimmunology|September 18, 2018
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBMAlice L Hung, Russell Maxwell, Debebe Theodros, et al.
Journal for Immunotherapy of Cancer|November 9, 2016
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial gliomaMira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2018
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and ImmunotherapyAriel E Marciscano, Ali Ghasemzadeh, Thomas R Nirschl, et al.
Cancer Immunology Research|May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder CancersMonali Praharaj, Fan Shen, Alex J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine GliomasJennifer E Kim, Mira A Patel, Antonella Mangraviti, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Research|May 25, 2019
Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic ProgressionRobert M Hughes, Brian W Simons, Hamda Khan, et al.
Journal for Immunotherapy of Cancer|May 19, 2016
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial gliomaMira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Oncoimmunology|September 18, 2018
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBMAlice L Hung, Russell Maxwell, Debebe Theodros, et al.
Journal for Immunotherapy of Cancer|November 9, 2016
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial gliomaMira A Patel, Jennifer E Kim, Debebe Theodros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2018
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and ImmunotherapyAriel E Marciscano, Ali Ghasemzadeh, Thomas R Nirschl, et al.
Cancer Immunology Research|May 3, 2024
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder CancersMonali Praharaj, Fan Shen, Alex J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine GliomasJennifer E Kim, Mira A Patel, Antonella Mangraviti, et al.
Pageof 3